Virtual Reality Hypnosis Versus Inhaled Nitrous Oxide in Anterior Shoulder Dislocation Reduction: an Open Multicenter Randomized Controlled Trial
1 other identifier
interventional
126
1 country
1
Brief Summary
Anterior shoulder dislocation (ASD) is a common situation in the emergency department (ED). Quick reductions lead to reduced mid and long term complications. No technique is superior to one another. Inhaled nitrous oxide can deal with pain reduction and anxiety but its efficacy is not optimal, with safety issues. Virtual reality hypnosis (VRH), by distracting patients from their pain, may lead to a better muscular relaxation and an easier ASD reduction. Our first objective is to evaluate the clinical interest of VHR compared to nitrous oxide, in ASD reduction. Our second objective is to evaluate the safety of VRH in ASD reduction. Patients over 18 years presenting an ASD \< 24 hours, will be illegible for enrollment in an open multicenter randomized controlled trial, conducted in the Great East Region in France.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 19, 2022
CompletedFirst Posted
Study publicly available on registry
May 24, 2022
CompletedStudy Start
First participant enrolled
October 9, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 9, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
January 9, 2024
CompletedFebruary 23, 2023
February 1, 2023
1 year
May 19, 2022
February 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reduction of ASD procedure time
Day 0
Secondary Outcomes (6)
Achievement of the reduction of ASD procedure
Day 0
Per-procedure pain
Day 0
Passage time in the ED
Day 0
Patient satisfaction
Day 0
Adverse events when using HRV
Day 0
- +1 more secondary outcomes
Study Arms (2)
Virtual reality hypnosis (VRH)
EXPERIMENTALNitrous oxide (NO)
ACTIVE COMPARATORInterventions
VRH offers predefined hypnosis sessions with no need of trained physician or nurse or caregiver mobilization. Consisting of a headset including headphones and a virtual reality screen, VRH allow patients to select a visual and sound environment (e.g.: tropical beach, space, underwater…) into which the hypnotic speech is delivered. That way, the patient's attention is distracted and muscular relaxation is obtained, a major relaxation factor. HRV is simple, quick, and presumably safe.
inhalation of NO usually used to help with ASD reduction but inhaled NO has safety and maintenance issues.
Eligibility Criteria
You may qualify if:
- patients of 18 years and older
- consulting the ED for a ASD \< 24 hours
- with or without history of ASD
- with social insurance
You may not qualify if:
- non anterior shoulder dislocation
- shoulder or facial fracture or multiple trauma patient
- dementia, psychosis
- uncontrolled epilepsy
- visual or hearing issues
- claustrophobia
- vascular or nervous lesion of the dislocated arm
- contraindication with the use of inhaled nitrous oxide
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CHU de Reimslead
Study Sites (1)
Damien JOLLY
Reims, France
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 19, 2022
First Posted
May 24, 2022
Study Start
October 9, 2022
Primary Completion
October 9, 2023
Study Completion
January 9, 2024
Last Updated
February 23, 2023
Record last verified: 2023-02